FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3088508847> ?p ?o ?g. }

• W3088508847 endingPage "100934" @default.
• W3088508847 startingPage "100934" @default.
• W3088508847 abstract "To report a case of impending central retinal vein occlusion (CRVO) associated with idiopathic cutaneous leukocytoclastic vasculitis (LCV) that demonstrated significant resolution following treatment with intravenous (IV) methylprednisolone.A 27-year-old man presented to a tertiary Uveitis Clinic with a five-day history of blurry vision in the right eye (OD). He had a history of a purpuric rash and arthralgias five years ago and a biopsy-confirmed diagnosis of LCV controlled with colchicine two years ago in India. Recently, he presented with a recurrent rash and severe abdominal pain. After being evaluated by rheumatology and gastroenterology, he was placed on Helicobacter pylori treatment and high dose oral prednisone, which improved his skin and gastrointestinal symptoms. At the first ophthalmic exam, his systemic findings included lower extremity purpura. His best-corrected visual acuity (BCVA) was 20/20 in both eyes (OU). Slit-lamp examination revealed no cells or flare in OU. Dilated fundus exam showed mild enlarged, tortuous veins, optic nerve hemorrhage, and intraretinal hemorrhages temporal to the macula in OD. Spectral-domain optical coherence tomography (SD-OCT) demonstrated multiple hyper-reflective, plaque-like lesions involving the inner nuclear layer, consistent with paracentral acute middle maculopathy (PAMM). The patient was diagnosed with impending central retinal vein occlusion (CRVO) in OD. Laboratory evaluations were unremarkable. Aspirin was initially started for the patient but was later held due to the worsening of retinal hemorrhage and retinal vein tortuosity at the one-week follow-up. The patient then received three doses of intravenous methylprednisolone, followed by systemic oral prednisone and mycophenolate mofetil. One month later, retinal hemorrhages, venous stasis, and skin manifestations resolved.Ocular involvement in LCV is rare and may present with different manifestations. The index case is the first report of impending CRVO in a patient with idiopathic LCV and without any other known risk factors for CRVO. Our report not only describes the unique course of LCV-related ocular involvement, but also introduces and underscores a potentially effective therapeutic plan." @default.
• W3088508847 created "2020-10-01" @default.
• W3088508847 creator A5003596747 @default.
• W3088508847 creator A5023260226 @default.
• W3088508847 creator A5031043376 @default.
• W3088508847 creator A5031108408 @default.
• W3088508847 creator A5048251212 @default.
• W3088508847 creator A5049843773 @default.
• W3088508847 creator A5050191788 @default.
• W3088508847 creator A5060241402 @default.
• W3088508847 creator A5061977147 @default.
• W3088508847 creator A5091022089 @default.
• W3088508847 date "2020-12-01" @default.
• W3088508847 modified "2023-10-14" @default.
• W3088508847 title "Impending central retinal vein occlusion in patient with idiopathic cutaneous leukocytoclastic vasculitis" @default.
• W3088508847 cites W142084292 @default.
• W3088508847 cites W1600560134 @default.
• W3088508847 cites W1806345065 @default.
• W3088508847 cites W1968884620 @default.
• W3088508847 cites W1969264267 @default.
• W3088508847 cites W1969516456 @default.
• W3088508847 cites W1994942912 @default.
• W3088508847 cites W1999074566 @default.
• W3088508847 cites W2010043290 @default.
• W3088508847 cites W2016881814 @default.
• W3088508847 cites W2025709358 @default.
• W3088508847 cites W2027821019 @default.
• W3088508847 cites W2029817191 @default.
• W3088508847 cites W2031517139 @default.
• W3088508847 cites W2035809865 @default.
• W3088508847 cites W2038691289 @default.
• W3088508847 cites W2040179604 @default.
• W3088508847 cites W2050987703 @default.
• W3088508847 cites W2060115585 @default.
• W3088508847 cites W2068779395 @default.
• W3088508847 cites W2069115606 @default.
• W3088508847 cites W2086594617 @default.
• W3088508847 cites W2087939340 @default.
• W3088508847 cites W2089694634 @default.
• W3088508847 cites W2093096944 @default.
• W3088508847 cites W2099968214 @default.
• W3088508847 cites W2107885708 @default.
• W3088508847 cites W2109568105 @default.
• W3088508847 cites W2110440340 @default.
• W3088508847 cites W2113939749 @default.
• W3088508847 cites W2138140436 @default.
• W3088508847 cites W2138991929 @default.
• W3088508847 cites W2146259646 @default.
• W3088508847 cites W2166768903 @default.
• W3088508847 cites W2168805315 @default.
• W3088508847 cites W2171857332 @default.
• W3088508847 cites W2173611605 @default.
• W3088508847 cites W2335690071 @default.
• W3088508847 cites W2403223424 @default.
• W3088508847 cites W2406245814 @default.
• W3088508847 cites W2417858964 @default.
• W3088508847 cites W2461598904 @default.
• W3088508847 cites W2745416595 @default.
• W3088508847 cites W2779096428 @default.
• W3088508847 cites W3008934644 @default.
• W3088508847 cites W3148465273 @default.
• W3088508847 cites W4210993658 @default.
• W3088508847 cites W4242921877 @default.
• W3088508847 cites W4248412463 @default.
• W3088508847 doi "https://doi.org/10.1016/j.ajoc.2020.100934" @default.
• W3088508847 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7522751" @default.
• W3088508847 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33015410" @default.
• W3088508847 hasPublicationYear "2020" @default.
• W3088508847 type Work @default.
• W3088508847 sameAs 3088508847 @default.
• W3088508847 citedByCount "4" @default.
• W3088508847 countsByYear W30885088472021 @default.
• W3088508847 countsByYear W30885088472023 @default.
• W3088508847 crossrefType "journal-article" @default.
• W3088508847 hasAuthorship W3088508847A5003596747 @default.
• W3088508847 hasAuthorship W3088508847A5023260226 @default.
• W3088508847 hasAuthorship W3088508847A5031043376 @default.
• W3088508847 hasAuthorship W3088508847A5031108408 @default.
• W3088508847 hasAuthorship W3088508847A5048251212 @default.
• W3088508847 hasAuthorship W3088508847A5049843773 @default.
• W3088508847 hasAuthorship W3088508847A5050191788 @default.
• W3088508847 hasAuthorship W3088508847A5060241402 @default.
• W3088508847 hasAuthorship W3088508847A5061977147 @default.
• W3088508847 hasAuthorship W3088508847A5091022089 @default.
• W3088508847 hasBestOaLocation W30885088471 @default.
• W3088508847 hasConcept C118487528 @default.
• W3088508847 hasConcept C141071460 @default.
• W3088508847 hasConcept C142724271 @default.
• W3088508847 hasConcept C16005928 @default.
• W3088508847 hasConcept C2775934546 @default.
• W3088508847 hasConcept C2776194053 @default.
• W3088508847 hasConcept C2776391266 @default.
• W3088508847 hasConcept C2778257484 @default.
• W3088508847 hasConcept C2778844676 @default.
• W3088508847 hasConcept C2780347916 @default.
• W3088508847 hasConcept C2780372218 @default.
• W3088508847 hasConcept C2780439664 @default.
• W3088508847 hasConcept C2908732032 @default.

• next